Hologic (HOLX) PT Lowered to $43 at Needham & Company; 'Ugly Write-Down for Aesthetics Business'

May 3, 2018 6:43 AM
Needham & Company lowered its price target on Hologic (NASDAQ: HOLX) to $43.00 (from $50.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles